Evidence map›Paper›PMID 29247063›Full record

ArticleGut2019

Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A.

Wouter B Nagengast, Elmire Hartmans, Pilar B Garcia-Allende, Frans T M Peters, Matthijs D Linssen, Maximilian Koch, Marjory Koller, Jolien J J Tjalma, Arend Karrenbeld, Annelies Jorritsma-Smit and 3 more

3 registry-linked trialsAbstract readNews
In one paragraph

Article in Gut, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03877601 phase2unknown statusnot on this map

A Prospective Follow-up Intervention Study: Detection of Early Esophageal Cancer by Near-infrared Fluoresence Molecular Endoscopy Using Bevacizumab-800CW

TypeinterventionalSponsorUniversity Medical Center GroningenRan2019 to 2021Enrolled60ConditionsBarrett EsophagusArmsBevacizumab-IRDye800CW, Fluorescence endoscopy
NCT04101292 nawithdrawnnot on this mapstarted 2021, after this paper: background citation

Endoscopic Optical Imaging for Precision Oncology Treatment Applied to Colorectal Tumours

TypeinterventionalSponsorIHU StrasbourgRan2021 to 2023Enrolled0ConditionsColorectal CancerArmsCharacterization of tumor tissue by fluorescence
NCT04112212 phase1completednot on this mapstarted 2020, after this paper: background citation

Using Fluorescently Labeled Vedolizumab to Visualize Local Drug Distribution During Colonoscopy and Identify Mucosal Target Cells in Patients With Inflammatory Bowel Disease

TypeinterventionalSponsorUniversity Medical Center GroningenRan2020 to 2023Enrolled38ConditionsCrohn Disease, Colitis, UlcerativeArmsFluorescence molecular imaging procedure using vedolizumab-800CW, Fluorescence molecular imaging procedure without prior administration of vedolizumab-800CW, Fluorescence molecular imaging procedure using vedolizumab-800CW with prior administration of unlabeled vedolizumab
3 · Its place in the literature

Who cites it

78 citing papers in PubMed.

  1. Targeted Fluorescence Imaging of Bevacizumab-800CW in Patients with Neovascular Age-Related Macular Degeneration.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Fluorescence Imaging of Cancer.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  11. Optical and Optoacoustic Imaging.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Targeting c-MET for Endoscopic Detection of Dysplastic Lesions within Barrett's Esophagus Using EMI-137 Fluorescence Imaging.Clinical cancer research : an official journal of the American Association for Cancer Research · 2025
    Article
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Wouter B Nagengast *Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center, Groningen, The Netherlands.
Elmire Hartmans *Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center, Groningen, The Netherlands.
Pilar B Garcia-AllendeChair for Biological Imaging and Institute for Biological and Medical Imaging, Technical University of Munich and Helmholtz Centre Munich, Munich, Germany.
Frans T M PetersDepartment of Gastroenterology and Hepatology, University of Groningen, University Medical Center, Groningen, The Netherlands.
Matthijs D LinssenDepartment of Gastroenterology and Hepatology, University of Groningen, University Medical Center, Groningen, The Netherlands.
Maximilian KochChair for Biological Imaging and Institute for Biological and Medical Imaging, Technical University of Munich and Helmholtz Centre Munich, Munich, Germany.
Marjory KollerDepartment of Surgery, University of Groningen, University Medical Center, Groningen, The Netherlands.
Jolien J J TjalmaDepartment of Gastroenterology and Hepatology, University of Groningen, University Medical Center, Groningen, The Netherlands.
Arend KarrenbeldDepartment of Pathology, University of Groningen, University MedicalCenter, Groningen, The Netherlands.
Annelies Jorritsma-SmitDepartment of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center, Groningen, The Netherlands.
Jan H KleibeukerDepartment of Gastroenterology and Hepatology, University of Groningen, University Medical Center, Groningen, The Netherlands.
Gooitzen M van DamDepartment of Surgery, University of Groningen, University Medical Center, Groningen, The Netherlands.
Vasilis NtziachristosChair for Biological Imaging and Institute for Biological and Medical Imaging, Technical University of Munich and Helmholtz Centre Munich, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Endoscopes, GastrointestinalAdenocarcinomaAntineoplastic Agents, ImmunologicalBarrett EsophagusBevacizumabEarly Detection of CancerEquipment DesignEsophageal NeoplasmsEsophagoscopyFemaleFluorescenceHumansImmunohistochemistryMaleSpectroscopy, Near-InfraredAntineoplastic Agents, ImmunologicalBevacizumabangiogenesisbarrettearly detectionimagingoesophageal cancertumor

Identifiers

PMID29247063
PMCPMC6839834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.